Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 2 | 2017 | 584 | 0.730 |
Why?
|
| Terminal Care | 1 | 2017 | 96 | 0.530 |
Why?
|
| Health Plan Implementation | 1 | 2016 | 40 | 0.520 |
Why?
|
| Pneumothorax | 2 | 2013 | 49 | 0.520 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 147 | 0.510 |
Why?
|
| Pulmonary Medicine | 2 | 2020 | 40 | 0.450 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 267 | 0.430 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2013 | 12 | 0.430 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 42 | 0.430 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 85 | 0.410 |
Why?
|
| International Classification of Diseases | 1 | 2013 | 131 | 0.410 |
Why?
|
| Internal Medicine | 1 | 2013 | 154 | 0.400 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 413 | 0.400 |
Why?
|
| Fellowships and Scholarships | 1 | 2013 | 99 | 0.390 |
Why?
|
| Biopsy, Needle | 1 | 2012 | 134 | 0.380 |
Why?
|
| Colitis, Ulcerative | 2 | 2009 | 71 | 0.380 |
Why?
|
| Clinical Competence | 2 | 2013 | 683 | 0.380 |
Why?
|
| Mass Screening | 1 | 2016 | 652 | 0.360 |
Why?
|
| Patient Safety | 1 | 2013 | 238 | 0.360 |
Why?
|
| Women's Health | 1 | 2013 | 360 | 0.350 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 317 | 0.350 |
Why?
|
| Veterans | 1 | 2017 | 728 | 0.330 |
Why?
|
| Capsule Endoscopes | 1 | 2009 | 2 | 0.330 |
Why?
|
| Quality of Health Care | 1 | 2013 | 514 | 0.320 |
Why?
|
| Critical Care | 1 | 2013 | 399 | 0.320 |
Why?
|
| Capsule Endoscopy | 1 | 2009 | 35 | 0.320 |
Why?
|
| Intestine, Small | 1 | 2009 | 77 | 0.310 |
Why?
|
| Crohn Disease | 1 | 2009 | 106 | 0.290 |
Why?
|
| Lung | 1 | 2012 | 920 | 0.280 |
Why?
|
| Internship and Residency | 1 | 2013 | 748 | 0.250 |
Why?
|
| Cohort Studies | 4 | 2013 | 2377 | 0.210 |
Why?
|
| Tracheomalacia | 1 | 2021 | 5 | 0.180 |
Why?
|
| Trachea | 1 | 2021 | 91 | 0.170 |
Why?
|
| Sarcoidosis, Pulmonary | 1 | 2020 | 14 | 0.170 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2021 | 37 | 0.170 |
Why?
|
| Retrospective Studies | 3 | 2017 | 6088 | 0.160 |
Why?
|
| United States | 3 | 2017 | 7431 | 0.150 |
Why?
|
| Humans | 11 | 2021 | 59479 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2020 | 137 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2020 | 170 | 0.150 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 2383 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 119 | 0.150 |
Why?
|
| Sarcoidosis | 2 | 2020 | 30 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 202 | 0.140 |
Why?
|
| Middle Aged | 5 | 2017 | 16342 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2516 | 0.140 |
Why?
|
| Bronchoscopy | 2 | 2020 | 86 | 0.140 |
Why?
|
| Pulmonologists | 1 | 2016 | 4 | 0.130 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 448 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 2341 | 0.130 |
Why?
|
| Veterans Health | 1 | 2016 | 158 | 0.120 |
Why?
|
| Female | 6 | 2021 | 30779 | 0.110 |
Why?
|
| Registries | 1 | 2017 | 804 | 0.110 |
Why?
|
| Male | 5 | 2017 | 27794 | 0.110 |
Why?
|
| Iatrogenic Disease | 1 | 2013 | 59 | 0.110 |
Why?
|
| Medicare | 1 | 2017 | 601 | 0.110 |
Why?
|
| Accreditation | 1 | 2013 | 73 | 0.100 |
Why?
|
| Risk Factors | 2 | 2013 | 4991 | 0.100 |
Why?
|
| Florida | 1 | 2012 | 42 | 0.100 |
Why?
|
| Aged | 3 | 2021 | 13426 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2012 | 259 | 0.090 |
Why?
|
| Electronic Health Records | 1 | 2013 | 345 | 0.090 |
Why?
|
| Mesalamine | 1 | 2009 | 3 | 0.080 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 14 | 0.080 |
Why?
|
| Curriculum | 1 | 2013 | 561 | 0.080 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 1561 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 1515 | 0.080 |
Why?
|
| Probability | 1 | 2009 | 168 | 0.080 |
Why?
|
| Biopsy | 2 | 2021 | 410 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2009 | 244 | 0.080 |
Why?
|
| Age Distribution | 1 | 2009 | 250 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2013 | 3072 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 5128 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2009 | 241 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2009 | 934 | 0.070 |
Why?
|
| Adult | 3 | 2013 | 15704 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 1029 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 1097 | 0.060 |
Why?
|
| Incidence | 1 | 2009 | 1239 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2009 | 1927 | 0.050 |
Why?
|
| Mouth | 1 | 2021 | 33 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2020 | 8 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2020 | 29 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 38 | 0.040 |
Why?
|
| Alkaline Phosphatase | 1 | 2020 | 46 | 0.040 |
Why?
|
| Endosonography | 1 | 2020 | 26 | 0.040 |
Why?
|
| Mediastinum | 1 | 2020 | 27 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2020 | 40 | 0.040 |
Why?
|
| Lymphadenopathy | 1 | 2020 | 23 | 0.040 |
Why?
|
| Eye Diseases | 1 | 2020 | 35 | 0.040 |
Why?
|
| Creatinine | 1 | 2020 | 128 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2020 | 215 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 200 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 92 | 0.040 |
Why?
|
| Vitamin D | 1 | 2020 | 132 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2020 | 338 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2020 | 524 | 0.030 |
Why?
|
| Echocardiography | 1 | 2020 | 458 | 0.030 |
Why?
|
| Calcium | 1 | 2020 | 557 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2057 | 0.020 |
Why?
|
| Social Support | 1 | 2009 | 355 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1483 | 0.010 |
Why?
|
| Quality of Life | 1 | 2009 | 1138 | 0.010 |
Why?
|